Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004.
Yalçin
Isik
I
Department of Paediatrics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Gürler
Nezahat
N
Alhan
Emre
E
Yaman
Akgün
A
Turgut
Mehmet
M
Celik
Umit
U
Akçakaya
Necla
N
Camcioğlu
Yildiz
Y
Diren
Sukufe
S
Yildirim
Bülent
B
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002439:Cefotaxime / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008826:Microbial Sensitivity Tests; D010400:Penicillin G / Q000494:pharmacology / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000187:drug effects* / Q000302:isolation & purification; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014421:Turkey / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D004917:Erythromycin; D019980:Amoxicillin-Potassium Clavulanate Combination; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002439:Cefotaxime; D010400:Penicillin G